Novo Nordisk pauses Wegovy marketing projects to dampen demand

Any publicity, even bad publicity, is good. So goes the old saying, but, for Novo Nordisk, too much publicity for its popular weight-loss drug Wegovy is becoming a bad thing, forcing the Danish drugmaker to turn off the marketing tap for the drug.